Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

87.78 -3.24 (-3.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
3 AI-Powered Healthcare Stocks Transforming Medicine
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029. 
Via InvestorPlace
Topics Artificial Intelligence
7 New Growth Stock Listings That Can Be Long-Term Wealth Creators
These are the new growth stocks to buy as they represent under-the-radar companies with sustained growth potential 
Via InvestorPlace
Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2
From Tempus AI, Inc.
Via Business Wire
Tempus Announces Expanded Data and Sequencing Collaboration with Remix Therapeutics
From Tempus AI, Inc.
Via Business Wire
3 AI-in-Healthcare Stocks to Buy for Outsized Returns
These are the AI healthcare stocks to buy as they represent medical technology investing in research and development for accelerated growth. 
Via InvestorPlace
Topics Artificial Intelligence
7 Growth Stocks That Can Create Millionaires by 2030
These are the millionaire-maker growth stocks to buy as they represent companies with good fundamentals and a big addressable market. 
Via InvestorPlace
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%), EXPI (+12%), ZETA (+11%), NATL (+11%). 
Via Benzinga
7 Millionaire-Making Growth Stocks to Buy and Forget
These are the millionaire-maker growth stocks to buy for the long term as they represent quality companies in a big addressable market. 
Via InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
A couple of the names you might not recognize -- yet. 
Via The Motley Fool
Tempus to Report Second Quarter 2024 Financial Results on August 6
From Tempus AI, Inc.
Via Business Wire
UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday
 
Via Benzinga
Tempus Expands Immuno-Oncology Portfolio with Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests
From Tempus AI, Inc.
Via Business Wire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The popular growth investor keeps adding to some of her favorite falling stocks. 
Via The Motley Fool
3 Under-the-Radar IPO Stocks to Buy Before They Double
These are the under-the-radar IPO stocks to buy as they represent growth companies with an attractive business outlook. 
Via InvestorPlace
Topics Initial Public Offering
IPOs 2024: Tempus AI Addresses Medical Diagnostic Use Case
Tempus has been growing at a strong clip. Its revenues increased from $257.9 million in 2021 to $320.7 million in 2022 and to $531.8 million last year. 
Via Talk Markets
Topics Artificial Intelligence
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
The funds are intended to launch a series of new biotech companies that will harness the power of generative artificial intelligence for drug discovery. 
Via Benzinga
Topics Artificial Intelligence
Tempus Surpasses 500 Research Publications
From Tempus AI, Inc.
Via Business Wire
Tempus AI Has Massive Market Opportunity For This Healthcare Technology, Bullish Analyst Says
William Blair initiated coverage on Tempus AI, highlighting its unique approach and business model in healthcare technology. The company, which leverages AI to analyze molecular, clinical, and genomic... 
Via Benzinga
Topics Artificial Intelligence Initial Public Offering
Tempus Could Gain Share In AI Health Care Market Poised To Grow By Over 30%
Tempus AI provides advanced technology to the healthcare and diagnostics market, which is expected to grow at +30%. 
Via Benzinga
Topics Artificial Intelligence
American Medical Association Grants PLA Code to Tempus Algorithmic Test, PurISTSM
From Tempus AI, Inc.
Via Business Wire
IPO Watch: 3 New Stocks Worth a Strong Look
Explore promising new IPOs in 2024, featuring standout companies like Tempus AI, Waystar, and Webtoon amid a revitalized market. 
Via InvestorPlace
Topics Artificial Intelligence Initial Public Offering
3 New IPOs That Could Be the Next Big Thing
Promising new IPOs are drawing interest after a robust H1 2024. Nasdaq's 66 IPOs raised $8.7B, marking a resurgence in U.S. markets. 
Via InvestorPlace
Why Tempus AI (TEM) Stock Is Rising
Tempus AI shares are trading higher by 7.3% during Tuesday's session. The company announced it was granted Advanced Diagnostic Laboratory Test status for its next-generation sequencing assay. 
Via Benzinga
Topics Artificial Intelligence
CMS Awards Tempus With Advanced Diagnostic Laboratory Test (ADLT) Status for its xT CDx Test
From Tempus AI, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We have the biggest pre-market stock movers that investors are going to want to start the trading week with on Monday morning! 
Via InvestorPlace
Trump Media & Technology And Grindr Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 23 - June 29): Are These In Your Portfolio?
Top performers last week: Tempus AI +30%, Enovix Corp +29%, Grindr Inc +27.5%, Trump Media +18.33%, Credo Tech +18.3%, Tecnoglass Inc +17.9%, STAAR Surgical +16.55%, RXO Inc +16.22%, Global-E Online... 
Via Benzinga
Topics Artificial Intelligence Government
Masayoshi Son's SoftBank To Raise $1.86B Through Bond Issuance For AI Investment And Debt Repayment
The funds raised will be used for "repayment of indebtedness and for general corporate purposes." 
Via Benzinga
Topics Artificial Intelligence
SoftBank Bets Big On AI In Healthcare: Inks New Joint Venture with Tempus To Transform Cancer Treatment In Japan
SoftBank Group and Tempus AI announced SB TEMPUS Corp., a joint venture to advance precision medicine in Japan using AI. Launching in July 2024, with each investing JPY 15.0 billion. 
Via Benzinga
Topics Artificial Intelligence
Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-AF, an AI-based Algorithm that Identifies Patients at Increased Risk of AFib
From Tempus
Via Business Wire
This AI Stock Surges Nearly 3% Premarket As SoftBank Reportedly Plans To Launch AI-Powered Medical Service In Japan
SoftBank Group is set to introduce a medical service in Japan that uses artificial intelligence to analyze personal medical data, including genetic information. The service will be launched through a... 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.